Christopher E. Helt
Impact in
-
- Carcinogens and Genotoxicity Assessment
- Cancer, Hypoxia, and Metabolism
-
- Cancer-related Molecular Pathways
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
- Carcinogens and Genotoxicity Assessment 2
- Oncology 8
- Cancer-related Molecular Pathways 7
- PARP inhibition in cancer therapy 2
- Co-authors
- Peter C. KengMichael A. O’ReillyRobert A. BambaraWilliam A. ClibyWensheng WangCarsten WeißJiyong ZhaoDirk Bohmann
- Journals
- American Journal of Physiology-Lung Cellular and Molecular Physiology (2 papers)Toxicological Sciences (1 paper)The EMBO Journal (1 paper)Cell Cycle (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United States
In The Last Decade
Christopher E. Helt
9 papers receiving 519 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 135
- Oncology 186
- Molecular Biology 417
- Aging 6
- Biotechnology 28
Countries citing papers authored by Christopher E. Helt
This map shows the geographic impact of Christopher E. Helt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Helt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Helt more than expected).
Fields of papers citing papers by Christopher E. Helt
This network shows the impact of papers produced by Christopher E. Helt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Helt. The network helps show where Christopher E. Helt may publish in the future.
Co-authorship network
The 18 scholars most cited alongside Christopher E. Helt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 15 | |
| 2 | 2006 | 14 | |
| 3 | 2005 | 17 | |
| 4 | 2005 | 68 | |
| 5 | 2004 | 32 | |
| 6 | 2004 | 151 | |
| 7 | 2004 | 107 | |
| 8 | 2001 | 77 | |
| 9 | 2001 | 42 |
About Christopher E. Helt
Christopher E. Helt is a scholar working on Cancer Research, Oncology, Biotechnology, Molecular Biology and Infectious Diseases, having authored 9 papers that have together received 523 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), DNA Repair Mechanisms (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (2 papers), Cancer Research and Treatments (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), PARP inhibition in cancer therapy (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (135 citations), Oncology (186 citations), Molecular Biology (417 citations), Aging (6 citations) and Biotechnology (28 citations). Christopher E. Helt has collaborated with scholars based in United States. Frequent co-authors include Peter C. Keng, Michael A. O’Reilly, Robert A. Bambara, William A. Cliby, Wensheng Wang, Carsten Weiß, Jiyong Zhao, Dirk Bohmann, Guang Gao and Sandra M. Schneider. Their work appears in journals such as American Journal of Physiology-Lung Cellular and Molecular Physiology, Toxicological Sciences, The EMBO Journal, Cell Cycle and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.